CD4+ T-lymphocytes and macrophages are the principal cellular reservoirs for primate lentivirus replication. However, there is a very limited understanding of processes influencing virus-macrophage interaction, nor is it clear as to the actual role played by the macrophage reservoir in viral replication. In the previous funding period we have garnered evidence to suggest that not only do macrophages provide conditions that may be highly advantageous for virus replication, but that the primate lentiviruses have evolved the ability to alter macrophage physiology in a way that enhances conditions for viral spread. These findings can be summarized as follows: 1. HIV-1, via the Nef protein, intersects the CD40 signaling pathway to promote the release of soluble factors that recruit T-cells to sites of viral replication and increase susceptibility of those cells to infection. 2. The ability of macrophages to sustain virus production requires induction of macrophage maintenance factors; an activity governed by the viral envelope glycoprotein. 3. HIV-1 assembles into cytoplasmic vesicles of infected macrophages. Virions within this compartment are highly stable and are transmitted to T-cells in trans. This points to a novel mechanism for viral persistence. In the next funding period we will define the biological significance of these activities in terms of viral replication and persistence in vitro and in vivo. Specifically, we propose to:
AIM 1 : Identify the mechanism by which primate lentiviruses intersect the CD40 signaling pathway in macrophages AIM 2: Define the mechanism by which HIV-1 induces macrophage maintenance factors and examine how they influence the outcome of the infection AIM 3: Characterize viral and cellular factors that influence the accumulation, stability and transmission of virions within cytoplasmic vesicles of infected macrophages.
AIM 4 : Examine in vivo characteristics of viruses altered in the ability to intersect CD40 signaling. These studies will define how macrophages contribute to primate lentiviral replication and pathogenicity and identify strategies through which to interrupt viral replication in this reservoir.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Project (R01)
Project #
5R01RR011589-13
Application #
7280318
Study Section
AIDS Immunology and Pathogenesis Study Section (AIP)
Program Officer
O'Neill, Raymond R
Project Start
1995-09-30
Project End
2009-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
13
Fiscal Year
2007
Total Cost
$460,695
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Kaushik, Rajnish; Zhu, Xiaonan; Stranska, Ruzena et al. (2009) A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe 6:68-80
Swingler, Simon; Zhou, Jin; Swingler, Catherine et al. (2008) Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe 4:63-76
Sharova, Natalia; Wu, Yuanfei; Zhu, Xiaonan et al. (2008) Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog 4:e1000057
Swingler, Simon; Mann, Angela M; Zhou, Jin et al. (2007) Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 3:1281-90
Sharova, Natalia; Swingler, Catherine; Sharkey, Mark et al. (2005) Macrophages archive HIV-1 virions for dissemination in trans. EMBO J 24:2481-9
Triques, Karine; Stevenson, Mario (2004) Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol 78:5523-7
Somasundaran, Mohan; Sharkey, Mark; Brichacek, Beda et al. (2002) Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci U S A 99:9503-8
Briggs, S D; Scholtz, B; Jacque, J M et al. (2001) HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. J Biol Chem 276:25605-11
Sharkey, M E; Teo, I; Greenough, T et al. (2000) Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med 6:76-81
Sleigh, R; Sharkey, M; Newman, M A et al. (1998) Differential association of uracil DNA glycosylase with SIVSM Vpr and Vpx proteins. Virology 245:338-43

Showing the most recent 10 out of 12 publications